Kissei Pharmaceutical Co., Ltd.
KSPHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $185,520,037 | $163,631,901 | $153,083,843 | $170,179,422 |
| - Cash | $245,550 | $28,823,000 | $25,169,000 | $18,667,000 |
| + Debt | $11,965 | $1,280,000 | $1,280,000 | $1,280,000 |
| Enterprise Value | $185,286,452 | $136,088,901 | $129,194,843 | $152,792,422 |
| Revenue | $159,806 | $22,191,000 | $22,661,000 | $23,203,000 |
| % Growth | -99.3% | -2.1% | -2.3% | – |
| Gross Profit | $78,470 | $11,080,000 | $10,947,000 | $11,720,000 |
| % Margin | 49.1% | 49.9% | 48.3% | 50.5% |
| EBITDA | $32,698 | $3,262,750 | $2,689,750 | $3,519,500 |
| % Margin | 20.5% | 14.7% | 11.9% | 15.2% |
| Net Income | $22,078 | $4,519,000 | $3,121,000 | $3,591,000 |
| % Margin | 13.8% | 20.4% | 13.8% | 15.5% |
| EPS Diluted | 0.53 | 107.87 | 72.91 | 82.99 |
| % Growth | -99.5% | 47.9% | -12.1% | – |
| Operating Cash Flow | – | $0 | $0 | $0 |
| Capital Expenditures | – | $0 | $0 | $0 |
| Free Cash Flow | – | $0 | $0 | $0 |